Lot of competitors in this COVID19 drug struggle for GRANT money.. The BIG BIOs I believe have an advantage here but this post is on a SMALLER than IPIX Canadian BIO company that is also seeking a piece. Will be a little PISSED if they get some and IPIX does not but not for their drug candidate.

Revive Therapeutics (RVVTF) has a Drug called Bucillamine they hope to get into a PHASE III trial for COVID19

Bring them up as they should have to endure the same struggles as our IPIX if anyone wants to follow them along with IPIX